ClinicalTrials.gov
ClinicalTrials.gov Menu

Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00761241
Recruitment Status : Completed
First Posted : September 29, 2008
Last Update Posted : May 26, 2010
Sponsor:
Collaborator:
Sanofi
Information provided by:
Benaroya Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2010
  Actual Study Completion Date : April 2010